|
|
||||||||
Departments of Cellular and Molecular Physiology, and Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Submitted 9 December 2003 ; accepted in final form 6 January 2004
Although an individual's genetic makeup is a major determinant of muscle mass, other influences, such as hormones, cytokines, nutrition, and exercise can also modulate muscle size. IL-6 is an important inflammatory cytokine. Mice that overexpress IL-6 fail to thrive and/or have reduced skeletal muscle mass. The purpose of the present study was to determine whether the stress hormone epinephrine increases inflammatory cytokine expression in skeletal muscle and muscle cells. Infusion of epinephrine in vivo for 2 h increased IL-6 protein (15-fold) and mRNA (40-fold) in skeletal muscle but not in liver. Epinephrine had a similar effect in C2C12 muscle cells, where the hormone increased IL-6 protein and mRNA in a dose- and time-dependent manner. Epinephrine-stimulated IL-6 expression was attenuated by the
-adrenergic receptor antagonist phentolamine and completely blocked by either the
1/2-adrenergic receptor antagonist propranalol or the
2-antagonist ICI-118551. The transcriptional inhibitor DRB and the synthetic glucocorticoid dexamethasone also blocked epinephrine-induced IL-6. SP-600125 (a JNK inhibitor) and SB-202190 (a p38 MAP kinase inhibitor) completely blocked epinephrine-induced IL-6 synthesis. Endotoxin and epinephrine given together had a synergistic affect on IL-6 mRNA and protein expression. Trichostatin A (a histone deacetylase inhibitor) blocked both endotoxin- and epinephrine-induced IL-6 expression. These data suggest that epinephrine induces IL-6 synthesis in skeletal muscle in vivo and myocytes in vitro. Epinephrine utilizes predominantly the
1/2-adrenergic receptors to stimulate IL-6 synthesis. Endotoxin and epinephrine synergize to increase IL-6 mRNA expression. Optimal IL-6 synthesis may require both stress kinase and histone deacetylase activity.
adrenergic receptors; interleukin-6
This article has been cited by other articles:
![]() |
M. KARALAKI, S. FILI, A. PHILIPPOU, and M. KOUTSILIERIS Muscle Regeneration: Cellular and Molecular Events In Vivo, September 1, 2009; 23(5): 779 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balasubramaniam, R. Joshi, C. Su, L. A. Friend, S. Sheriff, R. J. Kagan, and J. H. James Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R893 - R901. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kato, M. Kawaguchi, S. Inoue, K. Hirai, and H. Furuya The Effects of {beta}-Adrenoceptor Antagonists on Proinflammatory Cytokine Concentrations After Subarachnoid Hemorrhage in Rats Anesth. Analg., January 1, 2009; 108(1): 288 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Holmes, M. J. Watt, and M. A. Febbraio Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans J Appl Physiol, August 1, 2004; 97(2): 689 - 696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |